US › Healthcare

Addex Therapeutics Ltd (ADXN)

US · Healthcare · Biotechnology

$5.69+9.42%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$7,691
Revenue YoY
+410.0%
Net profit
$-1.7M
Profit YoY
-16.2%
EPS
$-1.33
Net margin
-22,256.4%

Key statistics

Market cap
$6.6M
Forward P/E
0.0
P/B
1.63
Book value
$4.12
EPS (TTM)
$-8.85
52-week high
$12.05
52-week low
$5.04
50-day MA
$6.13
200-day MA
$7.26
Beta
1.99

Analyst view

Analysts rate Addex Therapeutics Ltd a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $30.00.

Shareholding

Institutions
0.04%

Largest institutional holders

FundStake
Morgan Stanley - Brokerage Accounts0.03%
Rhumbline Advisers0.01%
SBI Securities Co Ltd0.00%
GAMMA Investing LLC0.00%
UBS Group AG0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Addex Therapeutics Ltd — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.